Cost-Effectiveness of Hypertension Treatment According to 2017 American College of Cardiology and American Heart Association Guidelines
Circulation: Cardiovascular Quality and Outcomes · 2025
DOI: 10.1161/circoutcomes.124.011872 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Circulation: Cardiovascular Quality and Outcomes, 2025. Verfasst von Joanne M Penko und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, University of California San Francisco, CA (J.M.P., S.H., R.B., P.G.C.). Hauptthemen laut MEDLINE: Hypertension, Antihypertensive Agents, Practice Guidelines as Topic, Blood Pressure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Compared with the 2003 Seventh Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7) guideline, the 2017 American College of Cardiology and American Heart Association guideline (ACC/AHA 2017) expanded hypertension diagnostic criteria to blood pressure (BP) ≥130/80 mm Hg and intensified treatment goals to
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, University of California San Francisco, CA (J.M.P., S.H., R.B., P.G.C.).
- Division of General Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY (B.K.B., Y.Z., A.E.M.).
- Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA (D.S.K.).
- Division of Cardiology, Department of Medicine, Vagelos College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY (L.G.).
- Division of General Internal Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital, CA (K.B.-D.).
ORCID-Profile: Brandon K Bellows, Susan Hennessy, Dhruv S Kazi, Yiyi Zhang, Lee Goldman, Kirsten Bibbins-Domingo, Andrew E Moran
Förderung
- NHLBI NIH HHS
Zitieren
APA
Penko, J. M., Bellows, B. K., Hennessy, S., Kazi, D. S., Boylan, R., Zhang, Y., Coxson, P. G., Goldman, L., Bibbins-Domingo, K., & Moran, A. E. (2025). Cost-Effectiveness of Hypertension Treatment According to 2017 American College of Cardiology and American Heart Association Guidelines. Circulation: Cardiovascular Quality and Outcomes. https://doi.org/10.1161/circoutcomes.124.011872
Vancouver
Penko JM, Bellows BK, Hennessy S, Kazi DS, Boylan R, Zhang Y, et al. Cost-Effectiveness of Hypertension Treatment According to 2017 American College of Cardiology and American Heart Association Guidelines. Circulation: Cardiovascular Quality and Outcomes. 2025. doi:10.1161/circoutcomes.124.011872
BibTeX
@article{Penko2025,
author = {Penko, Joanne M and Bellows, Brandon K and Hennessy, Susan and Kazi, Dhruv S and Boylan, Ross and Zhang, Yiyi and Coxson, Pamela G and Goldman, Lee and Bibbins-Domingo, Kirsten and Moran, Andrew E},
title = {Cost-Effectiveness of Hypertension Treatment According to 2017 American College of Cardiology and American Heart Association Guidelines},
journal = {Circulation: Cardiovascular Quality and Outcomes},
year = {2025},
doi = {10.1161/circoutcomes.124.011872}
}
EUVIMED